Lichen‐Derived Products 2020
DOI: 10.1002/9781119593249.ch8
|View full text |Cite
|
Sign up to set email alerts
|

A Review on Trends and Opportunity in Edible Lichens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Regarding lichens as a source of pigments, to date, about 246 studies have been carried out, mainly focused on medicine, biochemistry, and genetics (Figure 2b). It has been discovered that the dyes produced by the symbiosis of lichens have specific chemical components with bioactive and antimicrobial capacity that are difficult to find in other natural sources; however, these metabolites may vary depending on the type and area of growth of the plant (Yamamoto et al, 2015;Yusuf, 2020). Although in the case of the Peruvian Geolashon scientific studies are limited (Figure 2c), it is known that T. flavicans contain secondary metabolites such as vicanicin that has antioxidant (Shameera Ahamed et al, 2019), antimicrobial, anticancer (El-Garawani et al, 2020) and antidiabetic (Maulidiyah et al, 2020b), which the industry can use.…”
Section: Introductionmentioning
confidence: 99%
“…Regarding lichens as a source of pigments, to date, about 246 studies have been carried out, mainly focused on medicine, biochemistry, and genetics (Figure 2b). It has been discovered that the dyes produced by the symbiosis of lichens have specific chemical components with bioactive and antimicrobial capacity that are difficult to find in other natural sources; however, these metabolites may vary depending on the type and area of growth of the plant (Yamamoto et al, 2015;Yusuf, 2020). Although in the case of the Peruvian Geolashon scientific studies are limited (Figure 2c), it is known that T. flavicans contain secondary metabolites such as vicanicin that has antioxidant (Shameera Ahamed et al, 2019), antimicrobial, anticancer (El-Garawani et al, 2020) and antidiabetic (Maulidiyah et al, 2020b), which the industry can use.…”
Section: Introductionmentioning
confidence: 99%